跳至主要内容
临床试验/JPRN-UMIN000001700
JPRN-UMIN000001700已完成3 期

A randomized, multicenter, controlled trial of the effectiveness of nebulized therapy with 3% hypertonic saline solution compared with 0.9% saline solution in hospitalized infants with RS viral bronchiolitis. - Nebulized 3% hypertonic saline solution treatment in hospitalized infants with RS viral bronchiolitis.

Tokyo Metropolitan Children's medical center Hospital0 个研究点目标入组 120 人开始时间: 2009年2月10日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 12months-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)pCO2 is more than 60 mm Hg by venous blood gas or SpO2 is under 95 % under administration of oxygen. 2)diagnosed episode of wheezing previously. 3)Cerebral palsy, congenital heart desease, lung disease, muscular disorder, malformed syndrome, immune deficiency disorder 4)a patient who was born by premature birth equal to or less than several a week 35 weeks for gestational ages 5)a patients administrated palivizumab. 6)a patients with apnea 7)Judged a patients needed intubation by the physicians. 8)Judged inappropriate for this study by the physicians.

研究者

发起方
Tokyo Metropolitan Children's medical center Hospital

相似试验